Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo, Elaine S. Jaffe, James R. Cook, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1229-1253
Open Access | Times Cited: 921

Showing 1-25 of 921 citing articles:

Global burden of hematologic malignancies and evolution patterns over the past 30 years
Nan Zhang, Jinxian Wu, Qian Wang, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 128
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 106
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
Leticia Quintanilla-Martı́nez, Steven H. Swerdlow, Thomas Tousseyn, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 227-244
Open Access | Times Cited: 76
Primary central nervous system lymphoma
Andrés J.M. Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 72
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66
miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways
Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154363-154363
Closed Access | Times Cited: 56
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 39
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Martin Dreyling, Jeanette K. Doorduijn, Eva Giné, et al.
The Lancet (2024) Vol. 403, Iss. 10441, pp. 2293-2306
Open Access | Times Cited: 34
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 23, pp. 2143-2155
Open Access | Times Cited: 17
The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research
Sarah E. Coupland, Ming‐Qing Du, Judith A. Ferry, et al.
The Journal of Pathology (2024) Vol. 262, Iss. 3, pp. 255-270
Open Access | Times Cited: 15
B-cell non-Hodgkin lymphomas
Elisabeth Silkenstedt, Gilles Salles, Elı́as Campo, et al.
The Lancet (2024) Vol. 403, Iss. 10438, pp. 1791-1807
Closed Access | Times Cited: 15
Diffuse Large B-Cell Lymphoma/High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements: a study of 60 Cases
Do H. Kim, L. Jeffrey Medeiros, Jie Xu, et al.
Modern Pathology (2025), pp. 100710-100710
Closed Access | Times Cited: 1
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53
Karlo Perica, Nayan Jain, Michael Scordo, et al.
New England Journal of Medicine (2025) Vol. 392, Iss. 6, pp. 577-583
Closed Access | Times Cited: 1
Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management
Stephen M. Ansell
American Journal of Hematology (2022) Vol. 97, Iss. 11, pp. 1478-1488
Closed Access | Times Cited: 67
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 49
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
Brunangelo Falini, Giovanni Martino, Stefano Lazzi
Leukemia (2022) Vol. 37, Iss. 1, pp. 18-34
Open Access | Times Cited: 45
Chronic lymphocytic leukemia treatment algorithm 2022
Paul J. Hampel, Sameer A. Parikh
Blood Cancer Journal (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 42
The Immunology of DLBCL
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 32
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P. Treon, Alessandra Tedeschi, Jesús F. San Miguel, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 97-106
Open Access | Times Cited: 28
Spatial and molecular profiling of the mononuclear phagocyte network in Classic Hodgkin lymphoma
Benjamin Stewart, Martin Fergie, Matthew D. Young, et al.
Blood (2023)
Closed Access | Times Cited: 26
Updated guidelines for chronic active Epstein–Barr virus disease
Jun‐ichi Kawada, Yoshinori Ito, Koichi Ohshima, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 5, pp. 568-576
Open Access | Times Cited: 26
Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data
Katrin S. Kurz, Sabrina Kalmbach, Michaela Ott, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 785-785
Open Access | Times Cited: 25
Cutaneous B‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1326-1332
Open Access | Times Cited: 24
Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches
Elisabeth Silkenstedt, Martin Dreyling
Hematological Oncology (2023) Vol. 41, Iss. S1, pp. 36-42
Open Access | Times Cited: 24
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
Laura K. Hilton, Henry S. Ngu, Brett Collinge, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 25, pp. 4164-4177
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top